NVRO Nevro Corp

Nevro Corp develops and sells medical devices mainly in the United States. Its main product is the Senza system which is intended to relieve leg and spinal cord pain with the application of the HF10 therapy.

$33.13  +0.67 (2.06%)
As of 03/27/2023 14:19:07 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  11/06/2014
Outstanding shares:  35,535,183
Average volume:  544,227
Market cap:   $1,095,194,340
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BS7K7C9

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%